ARCHIVES

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Advisors say NCI needs to reach out to other fields.

July 15, 2005

Guest Editorial: MD Anderson’s Judith Smith Questions NCI Short-Term Remedy For Carboplatin Dosing

October 15, 2010

Possible Budget Balancing Effort Darkens Prospect For Increase In Cancer Budget

March 7, 1980

NCI-Approved Cancer Center, Cooperative Group Trials

April 27, 2007

NCI Not Following Congress Mandate, Zubrod Contends

April 28, 1978

NIH Faces Cuts Under House, Senate, Administration Plans

May 19, 1995